Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study
Authors:
- Masaki MachidaMMMasaki Machida
- Hiroyuki KikuchiHKHiroyuki Kikuchi
- Takako KojimaTKTakako Kojima
- Itaru NakamuraINItaru Nakamura
- Reiko SaitoReiko Saito
- Tomoki NakayaTNTomoki Nakaya
- Tomoya HanibuchiTHTomoya Hanibuchi
- Tomoko TakamiyaTTTomoko Takamiya
- Yuko OdagiriYOYuko Odagiri
- Noritoshi FukushimaNFNoritoshi Fukushima
- Shiho AmagasaSAShiho Amagasa
- Hidehiro WatanabeHWHidehiro Watanabe
Open Access
- 16 June 2022
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 18 (5) , 2086773
Abstract
To reduce vaccine hesitancy, it is important to identify factors that can intervene at the individual or community level. Social capital is a possible factor because it is associated with various vaccine hesitancy, such as for measles and influenza. However, limited studies have explored the association between social capital and vaccination for COVID-19, which is an unprecedented pandemic and infodemic. Therefore, this study aimed to clarify the association between social capital and COVID-19 vaccination during the pandemic. This cross-sectional study used quota sampling for an online-based survey. Participants were asked whether they had previously been vaccinated for COVID-19 and their intention to receive a COVID-19 vaccine booster. Social capital was evaluated using three measures (individual-level civic participation, social cohesion, and reciprocity). Multiple logistic regression analysis was performed to clarify the association between social capital and previous COVID-19 vaccination status as well as intention to receive a COVID-19 booster. Participants were 2,313 individuals, of whom 87.2% had received a COVID-19 vaccine; 72.3% intended to obtain a COVID-19 booster. Individuals with any social capital are more likely to receive a COVID-19 vaccination than those with none (OR: 1.73, 95%CI: 1.18–2.54; OR: 1.58, 95%CI: 1.22–2.05; OR: 3.05, 95%CI: 2.15–4.33). These indicators were also associated with the intention to receive a COVID-19 booster. Thus, our results suggest that among the general public, those with individual-level social capital are more likely to receive a COVID-19 vaccination than those with none. Social capital may be a factor that can reduce vaccine hesitancy during a pandemic.Keywords
Funding Information
- Tokyo Medical University
This publication has 39 references indexed in Scilit:
- Vaccine hesitancy: Definition, scope and determinantsVaccine, 2015
- Social Capital and Health-Protective Behavior Intentions in an Influenza PandemicPLOS ONE, 2015
- Social capital and immunization against the 2009 A(H1N1) pandemic in the American StatesPublic Health, 2014
- Social capital and the utilization of maternal and child health services in India: A multilevel analysisHealth & Place, 2014
- Associations between health communication behaviors, neighborhood social capital, vaccine knowledge, and parents’ H1N1 vaccination of their childrenVaccine, 2013
- Social capital and immunisation against the 2009 A(H1N1) pandemic in SwedenScandinavian Journal of Public Health, 2013
- Linkages between maternal education and childhood immunization in IndiaSocial Science & Medicine, 2012
- Influenza vaccine uptake among community-dwelling Italian elderly: results from a large cross-sectional studyBMC Public Health, 2011
- "Herd Immunity": A Rough GuideClinical Infectious Diseases, 2011
- Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strataVaccine, 2003